AU2002224901B2 - Method for diagnosing a tumor in a patient determining the concentration of PIBF - Google Patents

Method for diagnosing a tumor in a patient determining the concentration of PIBF Download PDF

Info

Publication number
AU2002224901B2
AU2002224901B2 AU2002224901A AU2002224901A AU2002224901B2 AU 2002224901 B2 AU2002224901 B2 AU 2002224901B2 AU 2002224901 A AU2002224901 A AU 2002224901A AU 2002224901 A AU2002224901 A AU 2002224901A AU 2002224901 B2 AU2002224901 B2 AU 2002224901B2
Authority
AU
Australia
Prior art keywords
pibf
tumor
concentration
fragment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002224901A
Other languages
English (en)
Other versions
AU2002224901A1 (en
Inventor
Tamas Henics
Christoph Klade
Margit Koch
Eszter Nagy
Tamas Palkovics
Beata Polgar
Julia Szekeres-Bartho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valneva Austria GmbH
Original Assignee
Intercell Austria AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Austria AG filed Critical Intercell Austria AG
Publication of AU2002224901A1 publication Critical patent/AU2002224901A1/en
Assigned to INTERCELL AG reassignment INTERCELL AG Request for Assignment Assignors: CISTEM BIOTECHNOLOGIES GMBH
Application granted granted Critical
Publication of AU2002224901B2 publication Critical patent/AU2002224901B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002224901A 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of PIBF Ceased AU2002224901B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT1997/2000 2000-11-28
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
PCT/EP2001/013876 WO2002044734A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf

Publications (2)

Publication Number Publication Date
AU2002224901A1 AU2002224901A1 (en) 2002-08-15
AU2002224901B2 true AU2002224901B2 (en) 2006-11-09

Family

ID=3689570

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002224901A Ceased AU2002224901B2 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of PIBF
AU2490102A Pending AU2490102A (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2490102A Pending AU2490102A (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf

Country Status (9)

Country Link
US (1) US20040142394A1 (https=)
EP (1) EP1337850B1 (https=)
JP (2) JP4025645B2 (https=)
AT (2) AT410753B (https=)
AU (2) AU2002224901B2 (https=)
CA (1) CA2431837A1 (https=)
DE (1) DE60127442T2 (https=)
ES (1) ES2283461T3 (https=)
WO (1) WO2002044734A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
US6207380B1 (en) * 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
DE69937998T2 (de) * 1998-07-02 2009-01-02 Envision Biomedical Consulting Antiproliferative und antivirale proteine und peptide
WO2001027633A1 (en) * 1999-10-08 2001-04-19 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Database EMBL [Online] AC: Y09631, XP002194124 *

Also Published As

Publication number Publication date
EP1337850A1 (en) 2003-08-27
ATA19972000A (de) 2002-12-15
CA2431837A1 (en) 2002-06-06
WO2002044734A1 (en) 2002-06-06
JP4025645B2 (ja) 2007-12-26
AT410753B (de) 2003-07-25
ATE357662T1 (de) 2007-04-15
JP2006230407A (ja) 2006-09-07
US20040142394A1 (en) 2004-07-22
DE60127442D1 (de) 2007-05-03
EP1337850B1 (en) 2007-03-21
DE60127442T2 (de) 2007-11-29
AU2490102A (en) 2002-06-11
JP2004514909A (ja) 2004-05-20
ES2283461T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
JP6490581B2 (ja) 修飾型自己エピトープに対する抗腫瘍免疫応答
US9316654B2 (en) TAZ/WWTR1 for diagnosis and treatment of cancer
US10066014B2 (en) Anti CD84 antibodies, compositions comprising same and uses thereof
JP2009514528A (ja) Ｎｋｇ２ｄ陽性ｃｄ４＋細胞による免疫応答の負の免疫調節法
CN101820894A (zh) 用于诊断和治疗癌症的vhz
AU2002224901B2 (en) Method for diagnosing a tumor in a patient determining the concentration of PIBF
AU2005219322B2 (en) Pharmaceutical Composition Comprising CXCR3 Inhibitor
AU2002224901A1 (en) Method for diagnosing a tumor in a patient determining the concentration of PIBF
MXPA06014972A (es) Metodos y composiciones para el tratamiento de enfermedades poliquisticas.
CN113398270B (zh) 一种治疗骨巨细胞瘤的方法
EP0582450A2 (en) Anti-oxytocin receptor antibodies and methods for their production
WO2003100428A2 (de) Verfahren zu diagnostizierung eines tumors bei einem patienten durch bestimmung von pibf
HK1165462A (en) In tumours differentially expressed gene products and use of the same
HK1165473A (en) In tumours differentially expressed gene products and use of the same
HK1165480A1 (zh) 肿瘤内差异表达的基因产物及其应用
HK1165474A (en) In tumours differentially expressed gene products and use of the same
HK1165467A (en) In tumours differentially expressed gene products and use of the same
HK1165465A (en) In tumours differentially expressed gene products and use of the same
HK1165470A (en) In tumours differentially expressed gene products and use of the same
HK1165485A (en) In tumours differentially expressed gene products and use of the same
HK1165472A (en) In tumours differentially expressed gene products and use of the same

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: INTERCELL AG

Free format text: FORMER APPLICANT(S): CISTEM BIOTECHNOLOGIES GMBH

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired